Insider · CIK 0001376960

Aryeh Jason

CIK 0001376960 Name as filed on the most recent filing

Filed as Aryeh Jason (95)

204 transaction lines · from 95 filings · filed 2007-06-01 to 2026-06-12 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

204 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2026-06-11 S, Open-market sale Ligand Pharmaceuticals IncLGND 1,125,000, disposed Open Form 4 filing 0002001011-26-000103
2026-06-10 S, Open-market sale Ligand Pharmaceuticals IncLGND 125,000, disposed Open Form 4 filing 0002001011-26-000103
2026-05-18 P, Open-market purchase Orchestra BioMed Holdings, Inc.OBIO 2,494, acquired Open Form 4 filing 0001104659-26-064136
2026-05-15 P, Open-market purchase Orchestra BioMed Holdings, Inc.OBIO 34,987, acquired Open Form 4 filing 0001104659-26-063511
2025-09-23 S, Open-market sale Ligand Pharmaceuticals IncLGND 3 lines 1,708,088, disposed Open Form 4 filing 0002001011-25-000082
2025-09-19 P, Open-market purchase Orchestra BioMed Holdings, Inc.OBIO 2,450, acquired Open Form 4 filing 0001104659-25-091775
2019-09-03 P, Open-market purchase Ligand Pharmaceuticals IncLGND 65,258, acquired Open Form 4 filing 0000886163-19-000163
2019-08-05 P, Open-market purchase Ligand Pharmaceuticals IncLGND 67,146, acquired Open Form 4 filing 0000886163-19-000145
2019-07-31 P, Open-market purchase Ligand Pharmaceuticals IncLGND 70,122, acquired Open Form 4 filing 0000886163-19-000132
2019-07-30 P, Open-market purchase Ligand Pharmaceuticals IncLGND 300,663, acquired Open Form 4 filing 0000886163-19-000132
2019-07-29 P, Open-market purchase Ligand Pharmaceuticals IncLGND 26,503, acquired Open Form 4 filing 0000886163-19-000132
2019-07-16 P, Open-market purchase Merrimack Pharmaceuticals IncMACK 1,643, acquired Open Form 4 filing 0000921895-19-002020
2019-07-12 P, Open-market purchase Merrimack Pharmaceuticals IncMACK 2 lines 19,324, acquired Open Form 4 filing 0000921895-19-002005
2019-07-11 P, Open-market purchase Merrimack Pharmaceuticals IncMACK 571, acquired Open Form 4 filing 0000921895-19-002005
2019-06-11 P, Open-market purchase Ligand Pharmaceuticals IncLGND 26,753, acquired Open Form 4 filing 0000886163-19-000115
2019-05-31 P, Open-market purchase Ligand Pharmaceuticals IncLGND 54,255, acquired Open Form 4 filing 0000886163-19-000090
2019-05-30 P, Open-market purchase Ligand Pharmaceuticals IncLGND 27,503, acquired Open Form 4 filing 0000886163-19-000090
2019-05-29 P, Open-market purchase Ligand Pharmaceuticals IncLGND 27,753, acquired Open Form 4 filing 0000886163-19-000090
2019-05-20 P, Open-market purchase Ligand Pharmaceuticals IncLGND 28,003, acquired Open Form 4 filing 0000886163-19-000085
2019-05-14 P, Open-market purchase Ligand Pharmaceuticals IncLGND 28,128, acquired Open Form 4 filing 0000886163-19-000083
2019-03-13 P, Open-market purchase Ligand Pharmaceuticals IncLGND 22,727, acquired Open Form 4 filing 0000886163-19-000054
2018-08-17 S, Open-market sale Ligand Pharmaceuticals IncLGND 6,495,559, disposed Open Form 4 filing 0000886163-18-000123
2018-08-16 S, Open-market sale Ligand Pharmaceuticals IncLGND 264,600, disposed Open Form 4 filing 0000886163-18-000123
2018-03-09 S, Open-market sale Ligand Pharmaceuticals IncLGND 705,899, disposed Open Form 4 filing 0000886163-18-000046
2018-03-08 S, Open-market sale Ligand Pharmaceuticals IncLGND 612,095, disposed Open Form 4 filing 0000886163-18-000046
2018-02-23 S, Open-market sale Ligand Pharmaceuticals IncLGND 529,635, disposed Open Form 4 filing 0000886163-18-000028
2017-11-17 S, Open-market sale Ligand Pharmaceuticals IncLGND 3,421,368, disposed Open Form 4 filing 0000886163-17-000144
2017-08-23 S, Open-market sale Ligand Pharmaceuticals IncLGND 255,980, disposed Open Form 4 filing 0000886163-17-000108
2017-05-23 S, Open-market sale Aralez Pharmaceuticals Inc.ARLZ 146,878, disposed Open Form 4 filing 0001104659-17-034708
2017-05-22 S, Open-market sale Aralez Pharmaceuticals Inc.ARLZ 332,365, disposed Open Form 4 filing 0001104659-17-034708
2017-05-19 S, Open-market sale Aralez Pharmaceuticals Inc.ARLZ 79,558, disposed Open Form 4 filing 0001104659-17-034708
2017-05-15 P, Open-market purchase Novelion Therapeutics Inc.NVLN 3,231, acquired Open Form 4 filing 0001104659-17-033512
2017-05-12 S, Open-market sale Ligand Pharmaceuticals IncLGND 1,631,334, disposed Open Form 4 filing 0000886163-17-000057
2017-05-11 S, Open-market sale Ligand Pharmaceuticals IncLGND 2,494,025, disposed Open Form 4 filing 0000886163-17-000057
2017-02-28 S, Open-market sale Ligand Pharmaceuticals IncLGND 753,060, disposed Open Form 4 filing 0000886163-17-000033
2017-02-27 S, Open-market sale Ligand Pharmaceuticals IncLGND 2,650,000, disposed Open Form 4 filing 0000886163-17-000033
2016-11-25 S, Open-market sale Ligand Pharmaceuticals IncLGND 372,007, disposed Open Form 4 filing 0000886163-16-000249
2016-11-22 S, Open-market sale Ligand Pharmaceuticals IncLGND 1,611,065, disposed Open Form 4 filing 0000886163-16-000249
2016-11-18 S, Open-market sale Ligand Pharmaceuticals IncLGND 525,000, disposed Open Form 4 filing 0000886163-16-000247
2016-11-16 S, Open-market sale Ligand Pharmaceuticals IncLGND 141,419, disposed Open Form 4 filing 0000886163-16-000247
2016-09-16 P, Open-market purchase Aralez Pharmaceuticals Inc.ARLZ 1,732,664, acquired Open Form 4 filing 0001104659-17-025903
2016-05-06 S, Open-market sale Ligand Pharmaceuticals IncLGND 1,777,833, disposed Open Form 4 filing 0000886163-16-000174
2016-05-05 S, Open-market sale Ligand Pharmaceuticals IncLGND 1,202,121, disposed Open Form 4 filing 0000886163-16-000174
2016-03-08 S, Open-market sale Ligand Pharmaceuticals IncLGND 51,245, disposed Open Form 4 filing 0000886163-16-000156
2016-03-07 S, Open-market sale Ligand Pharmaceuticals IncLGND 568,895, disposed Open Form 4 filing 0000886163-16-000156
2015-12-29 P, Open-market purchase QLT Inc/BCQLTI 2 lines 45,996, acquired Open Form 4 filing 0001140361-15-045998

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
S, Open-market sale
Open-market sale
P, Open-market purchase
Open-market purchase
Relationships on this page
D, Director
Director
%, Ten percent owner
Ten percent owner

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 88
  • Open-market sale 116
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. Aryeh Jason, insider transactions. Retrieved 2026-08-22 from https://ebomi.com/insider/0001376960

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.